InvestorsHub Logo
Followers 17
Posts 545
Boards Moderated 0
Alias Born 08/02/2013

Re: C-20 post# 200066

Tuesday, 01/11/2022 5:14:48 PM

Tuesday, January 11, 2022 5:14:48 PM

Post# of 232411
C, I don't know how you can blame much of this on Pourhassan. I'll just say this. 1-Running an undercapitalized business is a nightmare. Yes he is overpaid, I agree. But even if the board cut his pay in half, that really wouldnt make much of a difference in the big scheme of things. CYDY would still be scrambling for money, as are most pre rev biotechs. 2- going after Covid clearly slowed the HIV down. But when the Montefiore doc thought LL might help intubated covid patients, and it did help them, what did you want Pourhassan to do? Morally and financially, he had to go after it. And if we had a legit FDA, we would have been granted EUA, the stock would be 10 bucks and us longs would be happy. 3- along those lines, where would we be if the FDA granted BTD for the cancer? Again, stock would be rallying and we'd all be happy. And again, the FDA, rife with corruption, found a way to harrass us and throw up some more BS roadblocks. The game is rigged. That surely isnt NP's fault.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News